The improvement ffects of transcranial direct current stimulation (tDCS) on the symptoms in children with autism spectrum disorder (ASD)

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900027145

Enrollment

Unknown

Registered

2019-11-02

Start date

2019-11-15

Completion date

Unknown

Last updated

2019-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism spectrum disorder

Interventions

Group A:14 consecutive days of 1 mA anodal tDCS stimulation

Group B:14 consecutive days sham tDCS stimulation

Eligibility

Sex/Gender

All

Age

6 Years to 12 Years

Inclusion criteria

Inclusion criteria: 1. meet the diagnostic criteria for ASD; 2. patients aged 6-12 years, right-handed; 3. mild and moderate autistic symptoms (CARS score 30–36.5); 4. patients not receiving any medication related to autism at least 3 months before enrollment in this study; 5. during the treatment period, no other new therapeutic intervention was carried out voluntarily, and the original behavioral language rehabilitation therapy remains unchanged.

Exclusion criteria

Exclusion criteria: 1. metabolic defects, neurodegenerative diseases, brain tumor and intracranial infection or organic diseases of the central nervous system; 2. severe heart, liver and kidney diseases or malignant lesions; 3. epilepsy; 4. skull defect; 5. uncooperative patients or parents and caregivers.

Design outcomes

Primary

Measure	Time frame
Childhood Autism Rating Scale, CARS;Autism Treatment Evaluation Checklist, ATEC;Clinical Global Impression-Global Improvement, CGI-I;	—

Countries

China

Contacts

Public ContactQi Xiaohong

Xuanwu Hospital, Capital Medical University

meiwenqi001@yeah.net+86 13671094635

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026